TAKEDA "se queda"... con 2.800 (menos).

Takeda Pharmaceutical Co. (4502), Asia’s biggest drugmaker, plans to eliminate about 9 percent of its workforce over the next four years to integrate Nycomed, the Swiss company it’s targeting to spur profit from an 11-year low.
Takeda will cut 2,800 jobs, mainly in Europe and the U.S., to help yield net savings of about 130 billion yen ($1.7 billion) by the year ending March 31, 2016, the Osaka, Japan-based company said yesterday. The drugmaker said costs associated with the plan will trim 35 billion yen from net income in the current financial year, forecast in November to plunge 31 percent. (Más)